Literature DB >> 3288331

Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines.

K D Tew1, A M Bomber, S J Hoffman.   

Abstract

Ethacrynic acid and piriprost (6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1) have been shown to potentiate the cytotoxic activity of chlorambucil in rat and human tumor cell lines. Walker 256 rat breast carcinoma cells (WS), with acquired resistance to nitrogen mustards (WR), and two human colon carcinoma cell lines, HT 29 and BE, were sensitized to chlorambucil when either ethacrynic acid or piriprost was administered at the same time as the alkylating agent. Both as single agents and in combination with chlorambucil, there was inhibition of glutathione S-transferase activity as measured with 1-chloro-2,4-dinitrobenzene as a substrate. A depletion in intracellular glutathione was also evident following ethacrynic acid alone or in combination with chlorambucil. Thus, diuretic plant phenols or prostaglandin analogues may have potential therapeutic utility in combination with alkylating agents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288331

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Mechanisms of resistance to alkylating agents.

Authors:  G Damia; M D'Incalci
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  Metabolic enzyme considerations in cancer therapy.

Authors:  Amit K Jain; Sweta Jain; A C Rana
Journal:  Malays J Med Sci       Date:  2007-01

3.  Glutathione conjugation of chlorambucil: measurement and modulation by plant polyphenols.

Authors:  K Zhang; K P Wong
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

Review 4.  ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

Authors:  Young Hee Choi; Ai-Ming Yu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity.

Authors:  Danyelle M Townsend; Kenneth D Tew; Lin He; Jarrod B King; Marie H Hanigan
Journal:  Biomed Pharmacother       Date:  2008-09-07       Impact factor: 6.529

6.  Pharmacology of a mimetic of glutathione disulfide, NOV-002.

Authors:  Danyelle M Townsend; Kenneth D Tew
Journal:  Biomed Pharmacother       Date:  2008-09-17       Impact factor: 6.529

7.  Glutathione analogues as novel inhibitors of rat and human glutathione S-transferase isoenzymes, as well as of glutathione conjugation in isolated rat hepatocytes and in the rat in vivo.

Authors:  S Ouwerkerk-Mahadevan; J H van Boom; M C Dreef-Tromp; J H Ploemen; D J Meyer; G J Mulder
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Sex-dependent expression and growth hormone regulation of class alpha and class mu glutathione S-transferase mRNAs in adult rat liver.

Authors:  P K Srivastava; D J Waxman
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

9.  Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.

Authors:  A Canada; L Herman; K Kidd; C Robertson; D Trump
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.

Authors:  Desheng Lu; Jerry X Liu; Tomoyuki Endo; Haowen Zhou; Shiyin Yao; Karl Willert; Ingo G H Schmidt-Wolf; Thomas J Kipps; Dennis A Carson
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.